Pathstone Holdings »

Neurosense Therapeutics shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Neurosense Therapeutics (NRSN) shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Neurosense Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neurosense Therapeutics held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurosense Therapeutics by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2025-12-31 $13k 17k 0.77

More positions owned by Pathstone Holdings

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Crowdstrike Hldgs Cl A (CRWD)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Rus 1000 Etf (IWB)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p Scp Etf (IJR)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Pathstone Holdings

Top funds holding Neurosense Therapeutics

Yorkville Advisors Global
Meitav Dash Investments
Gts Securities
UBS Group
Commonwealth Equity Services
Two Sigma Investments
Squarepoint Ops
Pathstone Holdings
Geode Capital Management
Creative Planning
SBI Securities
Jones Financial Companies, L.L
Jessup Wealth Management

View all funds holding Neurosense Therapeutics